Clinical Experience with Extended-Release Tacrolimus in Older Adult Kidney Transplant Recipients: A Retrospective Cohort Study.

Spenser E JanuaryJennifer C HagopianNicole M NesselhaufKristin ProgarTimothy A HorwedelRowena Delos Santos

Published in: Drugs & aging (2021)

Older adult recipients required significantly lower LCP-Tac doses compared with younger recipients and with the FDA-labeled starting dose. There were no differences in graft outcomes or adverse effects in older adult patients who received LCP-Tac versus IR-Tac.

Keyphrases

community dwelling
middle aged
physical activity
type diabetes
kidney transplantation
pet imaging
skeletal muscle